Bullisch
$47.26
Szenariopreis
$46.230
-0.069 (-0.15%)Zum Schluss
Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through two segments, triple-net investments and operating portfolio. Its investments in healthcare-related real estate properties, are located in the United States, the United Kingdom and Canada, include skilled nursing facilities (SNFs), assisted living facilities (ALFs) (including care homes in the United Kingdom), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities and continuing care retirement communities. Its core portfolio consists of its long-term triple-net leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. Its portfolio of real estate investments includes over 1,022 healthcare facilities, located in 41 states, Washington, D.C., the United Kingdom and Jersey, and are operated or managed by 93 third-party operators or managers.
Omega Healthcare Investors Inc is a good buy right now due to its strong financial performance, highlighted by a net income of $360 million in Q2 2026, which translates to an EPS of $1.19, significantly above estimates. Additionally, the forward P/E ratio of 10.13 suggests that the stock is undervalued compared to its earnings potential. However, a risk to consider is the recent downgrade of price targets by analysts, with the lowest target being $48, indicating potential short-term price pressure.
Raymond James
$53
2026-10-06
Raymond James
2026-10-06
Kursziel
$53
Wells Fargo
$48
2026-09-01
Wells Fargo
2026-09-01
Kursziel
$48
Mizuho
$46
2026-08-31
Mizuho
2026-08-31
Kursziel
$46
Barclays
$50
2026-08-31
Barclays
2026-08-31
Kursziel
$50
Citi
$58
2026-08-04
Citi
2026-08-04
Kursziel
$58
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

Latest Rating Changes on Wall Street

Omega Healthcare Transitions Nursing Facilities to PACS Group

Omega Healthcare to Release Q3 2026 Earnings on November 3

PACS Group Acquires 32 Skilled Nursing Facilities in Florida

Omega Healthcare Investors Q2 2026 Earnings Call Highlights
Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through two segments, triple-net investments and operating portfolio. Its investments in healthcare-related real estate properties, are located in the United States, the United Kingdom and Canada, include skilled nursing facilities (SNFs), assisted living facilities (ALFs) (including care homes in the United Kingdom), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities and continuing care retirement communities. Its core portfolio consists of its long-term triple-net leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. Its portfolio of real estate investments includes over 1,022 healthcare facilities, located in 41 states, Washington, D.C., the United Kingdom and Jersey, and are operated or managed by 93 third-party operators or managers. It operates in the Real Estate sector (REAL ESTATE INVESTMENT TRUSTS industry).
Omega Healthcare Investors Inc is a good buy right now due to its strong financial performance, highlighted by a net income of $360 million in Q2 2026, which translates to an EPS of $1.19, significantly above estimates. Additionally, the forward P/E ratio of 10.13 suggests that the stock is undervalued compared to its earnings potential. However, a risk to consider is the recent downgrade of price targets by analysts, with the lowest target being $48, indicating potential short-term price pressure.
11 analysts cover OHI: 1 rate it Buy, 8 Hold and 2 Sell. The average price target is 46.44.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.